The ST2 pathway is involved in acute pancreatitis: A translational study in humans and mice

American Journal of Pathology

Volumn 180, Issue 6, 2012, Pages 2330-2339

  Ouziel, Romy ^a,b   Gustot, Thierry ^a,b   Moreno, Christophe ^a,b   Arvanitakis, Marianna ^b   Degré, Delphine ^a,b   Trépo, Eric ^a,b   Quertinmont, Eric ^a   Vercruysse, Vincent ^a   Demetter, Pieter ^b   Le Moine, Olivier ^a,b   McKenzie, Andrew N J ^c   Delhaye, Myriam ^b   Devière, Jacques ^a,b   Lemmers, Arnaud ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33; RECEPTOR; ST2 RECEPTOR; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSLATIONAL RESEARCH;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL DEGRANULATION; FEMALE; HUMANS; INTERLEUKINS; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MIDDLE AGED; PANCREAS; PANCREATITIS; PERITONEAL CAVITY; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84861595462     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.03.009     Document Type: Article

References (51)

1. S.J. Pandol, A.K. Saluja, C.W. Imrie, P.A. Banks Acute pancreatitis: bench to bedside [Erratum appeared in Gastroenterology 2007, 133:1056] Gastroenterology 132 2007 1127 1151
2. D.C. Whitcomb Clinical practice: acute pancreatitis N Engl J Med 354 2006 2142 2150
3. J. Mayer, B. Rau, F. Gansauge, H.G. Beger Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications Gut 47 2000 546 552
4. J.G. Norman, G. Fink, M. Franz, J. Guffey, G. Carter, B. Davison, C. Sexton, M. Glaccum Active interleukin-1 receptor required for maximal progression of acute pancreatitis Ann Surg 223 1996 163 169
5. G. Fink, J. Yang, G. Carter, J. Norman Acute pancreatitis-induced enzyme release and necrosis are attenuated by IL-1 antagonism through an indirect mechanism J Surg Res 67 1997 94 97
6. V. Carriere, L. Roussel, N. Ortega, D.A. Lacorre, L. Americh, L. Aguilar, G. Bouche, J.P. Girard IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo Proc Natl Acad Sci USA 104 2007 282 287
7. S. Ali, A. Mohs, M. Thomas, J. Klare, R. Ross, M.L. Schmitz, M.U. Martin The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription J Immunol 187 2011 1609 1616
8. C. Moussion, N. Ortega, J.P. Girard The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin' PLoS One 3 2008 e3331
9. M. Enoksson, K. Lyberg, C. Möller-Westerberg, P.G. Fallon, G. Nilsson, C. Lunderius-Andersson Mast cells as sensors of cell injury through IL-33 recognition J Immunol 186 2011 2523 2528
10. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, D.M. Gorman, J.F. Bazan, R.A. Kastelein IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
11. A.A. Chackerian, E.R. Oldham, E.E. Murphy, J. Schmitz, S. Pflanz, R.A. Kastelein IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex J Immunol 179 2007 2551 2555
12. W.P. Arend, G. Palmer, C. Gabay IL-1, IL-18, and IL-33 families of cytokines Immunol Rev 223 2008 20 38
13. S. Sanada, D. Hakuno, L.J. Higgins, E.R. Schreiter, A.N. McKenzie, R.T. Lee IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system J Clin Invest 117 2007 1538 1549
14. E.K. Brint, D. Xu, H. Liu, A. Dunne, A.N. McKenzie, L.A. O'Neill, F.Y. Liew ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance Nat Immunol 5 2004 373 379
15. M. Arvanitakis, M. Delhaye, V. De Maertelaere, M. Bali, C. Winant, E. Coppens, J. Jeanmart, M. Zalcman, D. Van Gansbeke, J. Devière, C. Matos Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis Gastroenterology 126 2004 715 723
16. E.L. Bradley 3rd A clinically based classification system for acute pancreatitis Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992 Arch Surg 128 1993 586 590
17. M.J. Townsend, P.G. Fallon, D.J. Matthews, H.E. Jolin, A.N. McKenzie T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary Th2 responses J Exp Med 191 2000 1069 1075
18. C. Moreno, C. Nicaise, T. Gustot, E. Quertinmont, N. Nagy, M. Parmentier, H. Louis, J. Devière Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice Am J Physiol Gastrointest Liver Physiol 291 2006 G1089 G1099
19. C. Niederau, R.A. Liddle, L.D. Ferrell, J.H. Grendell Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice Evidence for cholecystokinin as a major factor in the development of acute pancreatitis J Clin Invest 78 1986 1056 1063
20. M.C. Jamur, A.C. Grodzki, E.H. Berenstein, M.M. Hamawy, R.P. Siraganian, C. Oliver Identification and characterization of undifferentiated mast cells in mouse bone marrow Blood 105 2005 4282 4289
21. D. Xu, H.R. Jiang, P. Kewin, Y. Li, R. Mu, A.R. Fraser, N. Pitman, M. Kurowska-Stolarska, A.N. McKenzie, I.B. McInnes, F.Y. Liew IL-33 exacerbates antigen-induced arthritis by activating mast cells Proc Natl Acad Sci USA 105 2008 10913 10918
22. S. Kurup, R.R. Bhonde Analysis and optimization of nutritional set-up for murine pancreatic acinar cells J Pancreas 3 2002 8 15
23. L.B. Schwartz, D.D. Metcalfe, J.S. Miller, H. Earl, T. Sullivan Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis N Engl J Med 316 1987 1622 1626
24. S. Kaieda, K. Shin, P.A. Nigrovic, K. Seki, R.T. Lee, R.L. Stevens, D.M. Lee Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1) J Biol Chem 285 2010 21478 21486
25. P.N. Pushparaj, H.K. Tay, S.C. H'ng, N. Pitman, D. Xu, A. McKenzie, F.Y. Liew, A.J. Melendez The cytokine interleukin-33 mediates anaphylactic shock Proc Natl Acad Sci USA 106 2009 9773 9778
26. I. Leal-Berumen, P. Colon, J. Marshall IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide J Immunol 152 1994 5468 5476
27. D. Moulin, O. Donzé, D. Talabot-Ayer, F. Mézin, G. Palmer, C. Gabay Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells Cytokine 40 2007 216 225
28. K. Oshikawa, K. Kuroiwa, K. Tago, H. Iwahana, K. Yanagisawa, S. Ohno, S.I. Tominaga, Y. Sugiyama Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation Am J Respir Crit Care Med 164 2001 277 281
29. S. Tajima, K. Oshikawa, S. Tominaga, Y. Sugiyama The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis Chest 124 2003 1206 1214
30. K. Kuroiwa, T. Arai, H. Okazaki, S. Minota, S. Tominaga Identification of human ST2 protein in the sera of patients with autoimmune diseases Biochem Biophys Res Commun 284 2001 1104 1108
31. J.J. Hoogerwerf, M.W. Tanck, M.A. van Zoelen, X. Wittebole, P.F. Laterre, T. van der Poll Soluble ST2 plasma concentrations predict mortality in severe sepsis Intensive Care Med 36 2010 630 637
32. E.O. Weinberg, M. Shimpo, S. Hurwitz, S. Tominaga, J.L. Rouleau, R.T. Lee Identification of serum soluble ST2 receptor as a novel heart failure biomarker Circulation 107 2003 721 726
33. M. Shimpo, D.A. Morrow, E.O. Weinberg, M.S. Sabatine, S.A. Murphy, E.M. Antman, R.T. Lee Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation 109 2004 2186 2190
34. R. Kakkar, R.T. Lee The IL-33/ST2 pathway: therapeutic target and novel biomarker Nat Rev Drug Discov 7 2008 827 840
35. T. Gächter, A.K. Werenskiold, R. Klemenz Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts J Biol Chem 271 1996 124 129
36. B.P. Leung, D. Xu, S. Culshaw, I.B. McInnes, F.Y. Liew A novel therapy of murine collagen-induced arthritis with soluble T1/ST2 J Immunol 173 2004 145 150
37. H. Hayakawa, M. Hayakawa, A. Kume, S. Tominaga Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation J Biol Chem 282 2007 26369 26380
38. M. Dib, X. Zhao, X. Wang, R. Andersson Mast cells contribute to early pancreatitis-induced systemic endothelial barrier dysfunction Pancreatology 2 2002 396 401
39. D. Moritz, H. Rodewald, J. Gheyselinck, R. Klemenz The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors J Immunol 161 1998 4866 4874
40. Z. Allkhverdi, D. Smith, M. Comeau, G. Delespesse The ST2 ligand IL-33 potently activates and drives maturation of human mast cells J Immunol 179 2007 2051 2054
41. D. Closa, J. Roselló-Catafau, L. Fernández-Cruz, E. Gelpí Prostaglandin D2, F2 alpha, E2, and E1 in early phase of experimental acute necrohemorrhagic pancreatitis in rats Pancreas 9 1994 73 77
42. P. Mentula, M. Kylänpää, E. Kemppainen, K.K. Eklund, A. Orpana, P. Puolakkainen, R. Haapiainen, H. Repo Serum levels of mast cell tryptase, vascular endothelial growth factor and basic fibroblast growth factor in patients with acute pancreatitis Pancreas 27 2003 e29 e33
43. M. Iikura, H. Suto, N. Kajiwara, K. Oboki, T. Ohno, Y. Okayama, H. Saito, S.J. Galli, S. Nakae IL-33 can promote survival, adhesion and cytokine production in human mast cells Lab Invest 87 2007 971 978
44. L.H. Ho, T. Ohno, K. Oboki, N. Kajiwara, H. Suto, M. Iikura, Y. Okayama, S. Akira, H. Saito, S.J. Galli, S. Nakae IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals J Leukoc Biol 82 2007 1481 1490
45. D.E. Smith The biological paths of IL-1 family members IL-18 and IL-33 J Leukoc Biol 89 2011 383 392
46. A. Nishida, A. Andoh, H. Imaeda, T. Sugihara, O. Inatomi, H. Shiomi, Y. Fujiyama Expression of interleukin-1-like cytokine interleukin-33 and its receptor complex (ST2L and IL-1RAcP) in human pancreatic myofibroblasts Gut 59 2010 531 541
47. M. Kurowska-Stolarska, P. Kewin, G. Murphy, R.C. Russo, B. Stolarski, C.C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, W. Niedbala, A.N. McKenzie, M.M. Teixeira, F.Y. Liew, D. Xu IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4 J Immunol 181 2008 4780 4790
48. D. Xu, H.R. Jiang, Y. Li, P.N. Pushparaj, M. Kurowska-Stolarska, B.P. Leung, R. Mu, H.K. Tay, A.N. McKenzie, I.B. McInnes, A.J. Melendez, F.Y. Liew IL-33 exacerbates autoantibody-induced arthritis J Immunol 184 2010 2620 2626
49. T. Yasuda, T. Ueda, Y. Takeyama, M. Shinzeki, H. Sawa, T. Nakajima, T. Ajiki, Y. Fujino, Y. Suzuki, Y. Kuroda Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis Pancreas 33 2006 359 363
50. A. Masamune, T. Watanabe, K. Kikuta, K. Satoh, A. Kanno, T. Shimosegawa Nuclear expression of interleukin-33 in pancreatic stellate cells Am J Physiol Gastrointest Liver Physiol 299 2010 G821 G832
51. A.L. Rankin, J.B. Mumm, E. Murphy, S. Turner, N. Yu, T.K. McClanahan, P.A. Bourne, R.H. Pierce, R. Kastelein, S. Pflanz IL-33 induces IL-13-dependent cutaneous fibrosis J Immunol 184 2010 1526 1535